Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Press release

AegirBio: Aegirbio signs agreement with Salofa for the veterinary market and receives a first order worth approximately SEK 2 million.

Subgen AI

Aegirbio has signed a non-exclusive agreement with the Finnish company Salofa Oy. The agreement is for veterinary applications and gives Salofa access to AegirBio's instruments and MagnetoImmunoAssay (MIA) for its own development of tests in veterinary medicine.

With this agreement, AegirBio will, via its subsidiary Magnasense Technologies OY, sell its existing MagniaReader to Salofa, which will bring it to market with proprietary tests for horses, dogs and cats. Magnasense receives revenue from the sale of instruments and royalties on the disposable products ie. tests that Salofa sells for the instruments.

When the contract was signed, an order was added to the value of 195,000 Euro (approx. SEK 2 million) for year one.

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.